IL1B and lung carcinoma: Previously, most of views thought that IL-1β could induce P38 MAPK activation in gastric adenocarcinoma [26], and pretreatment of cells with tangeretin could inhibit IL-1β-induced P38 MAPK in human lung carcinoma cells [27].